|

Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)

RECRUITINGSponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Actively Recruiting
SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Started2017-01-03
Est. completion2026-12-29
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT05621304

Summary

Background: People who were born outside of the country are the largest group of adults infected with chronic hepatitis B virus (HBV) in the US. HBV affects the liver. If not treated, HBV infection can lead to serious liver disease, including cancer. One recent study showed that only 35% of foreign-born US adults were aware of their HBV infections. Foreign-born US adults may also have trouble getting proper care after they are diagnosed with HBV. In one small survey, language, cultural, and financial barriers were cited as the biggest reasons for not receiving care. To help more people with HBV, researchers want to learn how to find and overcome any barriers to care. Objective: This natural history study seeks to identify and better understand barriers that prevent foreign-born US adults from getting proper care for HBV infections. Eligibility: People aged 18 years and older with chronic HBV who were born outside of the US. Design: Participants will visit the NIH clinic 1 time. This visit will take about 20 minutes. Researchers will review participants medical records and collect information about their HBV. Participants will complete a survey. They will answer questions about: Where they came from. When they came to the US. How well they have adapted to living in the US. The health care they have received for HBV. Their age, gender, and education. Participants will be paid $10 for completing the survey.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
* INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

* Male or female, aged \>=18 years
* Diagnosed of chronic HBV (HBsAg-positive)
* Self-reported country of birth outside of the US

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

-Individuals not able to understand and sign the informed consent document will not be included in the study.

Conditions2

Chronic Hepatitis B Virus (Hbv)Liver Disease

Locations2 sites

California

1 site
University of Southern California
Los Angeles, California, 90033
Kali ZhouNot Listedkali.zhou@med.usc.edu

Maryland

1 site
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892
NIH Clinical Center Office of Patient Recruitment (OPR)800-411-1222ccopr@nih.gov

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.